Catalyst Wire Dossier Catalyst Wire Dossier

TYRUKO

natalizumab-sztn · Sandoz Inc
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TYRUKO, covering 2023-08-24 to 2026-07-23. Get the full timeline:

Most recent: FDA Approved: TYRUKO — Supplemental Application (Sandoz Inc)

See pricing